Dan Spiegelman

Dan Spiegelman Email and Phone Number

Biotechnology Finance @ Samsara BioCapital
Dan Spiegelman's Location
Palo Alto, California, United States, United States
Dan Spiegelman's Contact Details
About Dan Spiegelman

Dan Spiegelman is a Biotechnology Finance at Samsara BioCapital. He possess expertise in biotechnology, finance, business development, pharmaceutical industry.

Dan Spiegelman's Current Company Details
Samsara BioCapital

Samsara Biocapital

View
Biotechnology Finance
Dan Spiegelman Work Experience Details
  • Samsara Biocapital
    Venture Partner
    Samsara Biocapital Apr 2023 - Present
    Palo Alto, California, Us
    Working with Samsara BioCapital portfolio companies on financial strategy, planning, and execution as well as IPO readiness and finance team development.
    View
  • Kyverna Therapeutics
    Member Board Of Directors And Chairman Of The Audit Committee
    Kyverna Therapeutics Jun 2021 - Present
    Emeryville, California, Us
    View
  • Spruce Biosciences
    Member Board Of Directors And Chairman Of The Audit Committee
    Spruce Biosciences Sep 2020 - Present
    South San Francisco, California, Us
    View
  • Maze Therapeutics
    Member Board Of Directors And Chairman Of The Audit Committee
    Maze Therapeutics Mar 2020 - Present
    South San Francisco, California, Us
    View
  • Tizona Therapeutics, Inc.
    Chairman Of The Board
    Tizona Therapeutics, Inc. May 2019 - Present
    South San Francisco, Ca, Us
    View
  • Myriad Genetics
    Board Member
    Myriad Genetics Apr 2020 - Jun 2024
    Salt Lake City, Utah, Us
    Member Board of Directors and Audit Committee Chair Myriad Genetics (Nasdaq: MYGN) and Tizona Therapeutics (private)
    View
  • Opthea
    Board Member
    Opthea Sep 2020 - Mar 2024
    South Yarra, Vic, Au
    View
  • Biomarin
    Executive Vice President, Chief Financial Officer
    Biomarin May 2012 - Jan 2020
    San Rafael, Ca, Us
    Responsible for Finance, Tax, Accounting, Investor Relations and MIS. BioMarin develops and markets biologic and small molecule drugs for rare diseases. Oversaw growth from 3 approved products, 1,000 employee’s and $500M revenues to 7 approved products, 3,000 employee’s, approx. $2.0B in revenues and initial profitability. BioMarin has a commercial presence in over 70 countries.Completed over $2.5 billion in combined equity and debt financings. Expanded analyst coverage and directed IR activities during market cap expansion from $5 to $15 billion. Managed WW staff of 200.
    View
  • Independent Biotechnology Finance Professional
    Biotech Board And Consulting
    Independent Biotechnology Finance Professional May 2009 - May 2012
    Public Company Board of Directors and Chaiman Audit Committee: Affymax (AFFY), Anthera (ANTH), Cyclacel (CYCC), Omeros (OMER), Oncothyreon (ONTY).Private Company Board of Directors: Jennerex Pharmaceutcials, Filtini Inc, Sensitini Inc.Co- Founder and Chief Financial Officer: Rapidscan PharmaceuticalsConsulting: Elan Pharmaceuticals (NeoTope); Cardio Dx, Intekrin, Achaogen.
  • Cv Therapeutics
    Senior Vice President, Chief Financial Officer
    Cv Therapeutics Jan 1998 - May 2009
    Palo Alto, Ca, Us
    Responsible for Accounting, Finance, Investor Relations, Business Development and MIS. CV Therapeutics developed drugs for cardiovascular diseases and transitioned from a 60 person R&D company into a 500- person fully integrated R&D and commercial company with US approval for two products (Ranexa® and Lexiscan®) and for one product in Europe (Ranexa®) prior to its sales to Gilead Sciences.
    View
  • Genentech
    Treasurer
    Genentech Jul 1991 - Jan 1998
    South San Francisco, California, Us
    View

Dan Spiegelman Skills

Biotechnology Finance Business Development Pharmaceutical Industry

Dan Spiegelman Education Details

  • Stanford University Graduate School Of Business
    Stanford University Graduate School Of Business
  • Stanford University
    Stanford University
    Economics

Frequently Asked Questions about Dan Spiegelman

What company does Dan Spiegelman work for?

Dan Spiegelman works for Samsara Biocapital

What is Dan Spiegelman's role at the current company?

Dan Spiegelman's current role is Biotechnology Finance.

What is Dan Spiegelman's email address?

Dan Spiegelman's email address is ds****@****ces.com

What is Dan Spiegelman's direct phone number?

Dan Spiegelman's direct phone number is +141550*****

What schools did Dan Spiegelman attend?

Dan Spiegelman attended Stanford University Graduate School Of Business, Stanford University.

What skills is Dan Spiegelman known for?

Dan Spiegelman has skills like Biotechnology, Finance, Business Development, Pharmaceutical Industry.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.